medicaltranslations.gr began its journey in 2010 with a clear purpose: to bring linguistic precision, scientific understanding, and technological innovation together for the benefit of the Greek pharmaceutical industry. From the very beginning, our work was defined by complexity, responsibility, and trust—qualities that shaped not only our services but our identity.
Our early years were marked by rapid recognition from major pharmaceutical organisations across Europe and the United States. By 2007, we had already become a primary translation and localisation partner for several top‑tier Swiss, Danish, Italian, and US pharmaceutical companies, as well as leading Greek CROs and healthcare agencies. These partnerships were not transactional; they are long‑term collaborations built on reliability, accuracy, and deep domain expertise.
As our reputation grew, so did the scope of our work. Throughout the 2010s, we supported regulatory submissions for EMA, delivered on‑site linguistic services during FDA and EMA clinical trial inspections, and provided language consultancy to major US localisation agencies. These experiences strengthened our operational maturity and positioned us as a trusted partner in high‑stakes, highly regulated environments.
Our commitment to scientific integrity and patient‑centric communication led us to undertake specialised projects such as the localisation of the Recommendations for a Global Curriculum in Medical Oncology for HESMO, and the full linguistic validation of PRO instruments using rigorous, independent methodologies. Each project reinforced our belief that language is not merely a tool—it is a critical component of healthcare quality.
In 2022, we reached a defining milestone: transitioning to a corporate structure that reflected our growth, our vision, and our expanding international footprint. That same year, we were honoured to be recognised by Healthcare Business Review as one of Europe’s emerging top 10 medical translation companies—an acknowledgment of nearly two decades of dedication to excellence.
By 2023, our evolution continued with the expansion of our services to include the development of language infrastructures and multilingual support across Western, Central, and Eastern Europe. This step marked our transformation from a specialised provider into a broader linguistic solutions partner for the life sciences sector.
Today, medicaltranslations.gr stands as a mature, forward‑thinking organisation shaped by collaboration, expertise, and innovation. Our story is one of continuous growth, but our mission remains unchanged: to deliver language solutions that meet the highest scientific, regulatory, and technological standards—because in healthcare, every word matters.
medicaltranslations.gr 